| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 3 159-166, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
R Hass, H Gunji, M Hirano, R Weichselbaum and D Kufe
Laboratory of Clinical Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.
Treatment of human U-937 myeloid leukemia cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) is associated with growth arrest and induction of monocytic differentiation. The present results demonstrate that exposure of G1- or S phase-enriched U-937 cells to TPA was associated with delayed transition through G2-M and then exit from the cell cycle in the subsequent G0-G1 phase. In contrast, G2-M cells treated with TPA progressed through G1-S, were delayed in the next G2-M phase, and then entered a nonproliferative G0-G1 state. The effects of TPA on expression of cell cycle control genes demonstrated down-regulation of the cdc25 mitotic inducer during S-G2 progression. In order to investigate the role of cdc25 in the control of cell cycle progression, U-937 cells were stably transfected with an antisense cdc25 construct under control of a metallothionein-inducible promoter. Expression of this construct in G1 phase cells was associated with a significant delay in transition through S and G2-M phase. Similar results were obtained when G1 phase cells were incubated with a 14-base pair antisense cdc25 oligomer. Taken together, these results indicate that the cdc25 gene product is functionally associated with S-G2 transition of proliferating myeloid leukemia cells and that down-regulation of this gene by TPA is associated with G2-M delay.
This article has been cited by other articles:
![]() |
A. Besson and V. W. Yong Involvement of p21Waf1/Cip1 in Protein Kinase C Alpha-Induced Cell Cycle Progression Mol. Cell. Biol., July 1, 2000; 20(13): 4580 - 4590. [Abstract] [Full Text] |
||||
![]() |
K. Detjen, F. Brembeck, M Welzel, A Kaiser, H Haller, B Wiedenmann, and S Rosewicz Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest J. Cell Sci., January 9, 2000; 113(17): 3025 - 3035. [Abstract] [PDF] |
||||
![]() |
C. Asiedu, J. Biggs, and A. S. Kraft Complex Regulation of CDK2 During Phorbol Ester-Induced Hematopoietic Differentiation Blood, November 1, 1997; 90(9): 3430 - 3437. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kiley and P. Parker Differential localization of protein kinase C isozymes in U937 cells: evidence for distinct isozyme functions during monocyte differentiation J. Cell Sci., January 3, 1995; 108(3): 1003 - 1016. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |